KR20140127705A - Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same - Google Patents

Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same Download PDF

Info

Publication number
KR20140127705A
KR20140127705A KR20130046401A KR20130046401A KR20140127705A KR 20140127705 A KR20140127705 A KR 20140127705A KR 20130046401 A KR20130046401 A KR 20130046401A KR 20130046401 A KR20130046401 A KR 20130046401A KR 20140127705 A KR20140127705 A KR 20140127705A
Authority
KR
South Korea
Prior art keywords
cdcl
compound
layer
light emitting
chemical shift
Prior art date
Application number
KR20130046401A
Other languages
Korean (ko)
Inventor
이칠원
박미영
최란
이현석
최연길
전영민
김준우
Original Assignee
대주전자재료 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대주전자재료 주식회사 filed Critical 대주전자재료 주식회사
Priority to KR20130046401A priority Critical patent/KR20140127705A/en
Publication of KR20140127705A publication Critical patent/KR20140127705A/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/125OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light
    • H10K50/13OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/656Aromatic compounds comprising a hetero atom comprising two or more different heteroatoms per ring
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to pyridine-pyrimidine derivatives represented by the following chemical formula 1 and an organic light emitting diode having excellent efficiency by comprising the same pyridine-pyrimidine derivatives in one or more organic layers. The pyridine-pyrimidine derivatives and the organic light emitting diode comprising the same according to the present invention are excellent in luminous efficiency and heat stability and applicable to all luminous layers ranging between red and blue phosphorescence, thereby being able to be used in various organic light emitting diodes for a flat panel display of a wall-mountable TV, lights, or a backlight of a display. [Chemical formula 1] In the chemical formula 1, R1 is anyone selected from the group comprised of phenyl, dibenzo[b,d]furanyl, and dibenzo [b,d]thienyl, and R2 is anyone selected from the group comprised of tert-butyl, trimethylsilanyl, phenyl, and mesityl.

Description

피리딘-피리미딘계 유도체 및 이를 포함하는 유기전기발광소자 {Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same}Pyridine-Pyrimidine Derivatives and Organic Electroluminescent Devices Including the Same -

본 발명은 발광 효율 및 열안정성 등이 우수한 신규한 피리딘-피리미딘 유도체, 및 이를 하나 이상의 유기층에 포함함으로써 우수한 효율 특성을 나타내는 유기전기발광소자에 관한 것이다.The present invention relates to novel pyridine-pyrimidine derivatives having excellent light-emitting efficiency and thermal stability, and organic electroluminescent devices exhibiting excellent efficiency characteristics by incorporating them into one or more organic layers.

유기전기발광소자는 자기발광형 발광소자로, 타 발광소자에 비해 구조가 단순하여 제조 공정이 간단하고, 응답속도가 빠르고 구동전압이 낮아, 벽걸이 TV 등의 평판 디스플레이 또는 디스플레이의 배면광, 조명, 광고판 등의 광원으로서 응용성이 증대되고 있다. 유기 전기발광 현상은 1969년 쿠르니(Curnee)에 의해서 공지(US 특허 제3,172,862호)된 이래 실용적인 측면에서 한계를 보여 왔으나, 1987년 이스트만 코닥사의 연구진에 의해서 기존의 문제점을 극복한 유기전기발광소자가 개발됨에 따라 이후 급속히 발전되어 왔다.The organic electroluminescent device is a self-luminous type light emitting device, which has a simpler structure than other light emitting devices, has a simple manufacturing process, has a high response speed and low driving voltage, The applicability as a light source such as a billboard is increasing. Organic electroluminescence phenomenon has been limited in practical terms since it was announced by Curnee in 1969 (US Pat. No. 3,172,862). However, the organic electroluminescent device which overcome the existing problems by the researchers of Eastman Kodak Company in 1987 Has developed rapidly since then.

일반적으로, 유기전기발광소자는 음극(전자주입전극)과 양극(정공주입전극), 및 상기 두 전극 사이에 하나 이상의 유기층을 포함하는 구조를 갖는다.Generally, an organic electroluminescent device has a structure including a cathode (electron injection electrode), an anode (hole injection electrode), and at least one organic layer between the two electrodes.

이때, 유기전기발광소자는 유기층으로서 발광층(EML, light emitting layer) 이외에, 정공주입층(HIL, hole injection layer), 정공수송층(HTL, hole transportlayer), 전자수송층(ETL, electron transport layer) 또는 전자주입층(EIL,electron injection layer)을 포함할 수 있으며, 발광층의 발광특성상, 전자차단층(EBL, electron blocking layer) 또는 정공차단층(HBL, hole blocking layer)을 추가로 포함할 수 있다. 이들 유기층을 모두 포함하는 유기전기발광소자는 양극/정공주입층/정공수송층/전자차단층/발광층/정공차단층/전자수송층/전자주입층/음극 순으로 적층된 구조를 갖는다.In this case, the organic electroluminescent device may include, as an organic layer, a hole injection layer (HIL), a hole transport layer (HTL), an electron transport layer (ETL), or an electron transport layer (ETL) And may further include an electron injection layer (EIL), and may further include an electron blocking layer (EBL) or a hole blocking layer (HBL) on the light emitting property of the light emitting layer. The organic electroluminescent device including all of these organic layers has a stacked structure in the order of anode / hole injecting layer / hole transporting layer / electron blocking layer / light emitting layer / hole blocking layer / electron transporting layer / electron injecting layer / cathode.

이러한 구조의 유기전기발광소자에 전기장을 인가하면, 양극으로부터 주입된 정공과 음극으로부터 주입된 전자가 재결합(recombination)하여 전자-정공 쌍인 엑시톤(exiton)을 형성하며, 이 엑시톤의 에너지가 발광 재료에 전달됨에 따라 빛이 방출된다. 적층형 유기전기발광소자의 수명은 재료의 전기화학적 안정성 및 박막 안정성 등과 관련이 깊다.When an electric field is applied to the organic electroluminescent device having such a structure, the holes injected from the anode and the electrons injected from the cathode are recombined to form an electron-hole pair exciton, Light is emitted as it is transmitted. The lifetime of the stacked organic electroluminescent device is related to the electrochemical stability and the thin film stability of the material.

예컨대, 열안정성이 좋지 않은 발광 물질을 사용할 경우에는 고온 또는 구동온도에서 상기 재료의 결정화가 이루어져 소자의 수명이 단축된다. 안트라센 유도체는 대표적인 유기 전기발광 소자용 재료로 발광층을 비롯하여 정공수송층 및 전자수송층에 등에 이용되어 왔다. 대표적인 예로 9,10-다이(나프탈렌-2-일)안트라센의 경우 발광층의 호스트 재료로 이용하고 있으나, 소자의 온도가 상승함에 따라 쉽게 결정화되어 소자의 수명이 짧은 단점이 있다. 이러한 단점을 극복하기 위해서 다양한 형태의 재료가 개발되고 있으나, 현재까지는 요구되는 발광효율, 구동 안정성 그리고 수명 등의 특성을 충분히 만족하지 못하고 있는 실정이어서 다양한 기술개발이 시급하다.For example, when a light emitting material having poor heat stability is used, crystallization of the material occurs at a high temperature or at a driving temperature, and the lifetime of the device is shortened. An anthracene derivative has been used for a typical organic electroluminescence device as a light emitting layer, a hole transporting layer, an electron transporting layer, and the like. As a typical example, 9,10-di (naphthalen-2-yl) anthracene is used as a host material for a light emitting layer. However, it is easily crystallized as the temperature of the device rises, shortening the lifetime of the device. In order to overcome such shortcomings, various types of materials have been developed. However, until now, characteristics such as required luminous efficiency, driving stability, and life span are not sufficiently satisfied.

이에 본 발명자는, 우수한 발광 효율 및 열안정성을 가지는 신규한 화합물을 연구하던 중, 피리딘-피리미딘계 유도체가 상기 과제를 해결할 수 있음을 확인하여 본 발명을 완성하였다.
Accordingly, the present inventors have found that pyridine-pyrimidine derivatives can solve the above problems while studying a novel compound having excellent luminescence efficiency and thermal stability, thereby completing the present invention.

본 발명의 목적은 발광 효율 및 열안정성이 우수하면서 적색 및 청색인광까지의 모든 발광층에 적용할 수 있는 피리딘-피리미딘계 유도체, 및 이를 유기층에 포함하는 유기발광소자를 제공하는 것이다.
An object of the present invention is to provide a pyridine-pyrimidine derivative which is excellent in luminous efficiency and thermal stability and can be applied to all the light emitting layers up to red and blue phosphorescence, and an organic light emitting device including the pyridine-pyrimidine derivative in the organic layer.

상기 목적을 달성하기 위하여 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:In order to accomplish the above object, the present invention provides a compound represented by the following Formula 1:

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

상기 식에서, R1은 페닐, 다이벤조[b,d]퓨라닐(dibenzo[b,d]furanyl) 및 다이벤조[b,d]싸이에닐(dibenzo[b,d]thienyl)로 구성된 군으로부터 선택되는 어느 하나이고, Wherein R 1 is selected from the group consisting of phenyl, dibenzo [b, d] furanyl and dibenzo [b, d] thienyl Which is selected,

R2는 터트-뷰틸, 트리메틸실라닐, 페닐, 및 메시틸(mesityl)로 구성된 군으로부터 선택되는 어느 하나이다.
R 2 is any one selected from the group consisting of tert-butyl, trimethylsilanyl, phenyl, and mesityl.

상기 화학식 1의 화합물은 2-(페닐설포닐)피리딘의 구조를 중심으로 하여 비대칭형의 카바졸기, 다이벤조퓨라닐기 또는 다이벤조싸이에닐기가 결합 또는 치환되어 있는 구조이다.
The compound of formula (1) is a structure in which an asymmetric carbazole group, dibenzofuranyl group or dibenzothienyl group is bonded or substituted with respect to the structure of 2- (phenylsulfonyl) pyridine.

바람직하게는, 상기 화합물은 하기 화학식 1a 또는 하기 화학식 1b로 표시되는 화합물 중 어느 하나이다.Preferably, the compound is any one of compounds represented by the following general formula (1a) or (1b).

[화학식 1a][Formula 1a]

Figure pat00002
Figure pat00002

[화학식 1b][Chemical Formula 1b]

Figure pat00003
Figure pat00003

또한 바람직하게는, 상기 R2가 카바졸의 6번 또는 7번 위치에 치환된 것을 특징으로 한다.Also preferably, the R 2 is substituted at the position 6 or 7 of the carbazole.

[화학식 1][Chemical Formula 1]

Figure pat00004

Figure pat00004

한편, 소자 구동시 상승되는 온도(대개 100℃ 미만)에 의해 무정형 박막이 결정형 형태로 이루어지면서 수명이 급격히 떨어지게 되는데, 내열성 증진으로 이러한 특성이 향상된다. 또, 박막안정성이란 막의 균일도 및 타층 재료와의 인터페이스 안정성 등을 의미하며, 구동안정성 (안정적인 전류밀도 등)에 영향을 준다.
On the other hand, the amorphous thin film is formed into a crystalline form due to the temperature (usually less than 100 캜) which is raised at the time of driving the device, and the lifetime is drastically decreased. The thin film stability means the uniformity of the film and the interface stability with the other layer materials, and affects the driving stability (stable current density, etc.).

OLED 재료에서의 내열성은 녹는점 및 유리전이 온도와 관련이 높다. 이러한 내열성은 분자 견고성 및 분자량에 직접적인 연관이 있다. 즉, 분자량이 높을수록 내열성이 좋아지는 경향이 있으며, 비슷한 분자량에서도 자유회전이 가능한 치환기나, 선형지방족 탄화수소치환기가 도입된 분자들이 도입된 경우 내열성이 떨어지는 경향이 있다.
Heat resistance in OLED materials is related to melting point and glass transition temperature. This heat resistance is directly related to molecular firmness and molecular weight. That is, the higher the molecular weight, the better the heat resistance. Also, when a substituent capable of free rotation at a similar molecular weight or a molecule containing a linear aliphatic hydrocarbon substituent is introduced, the heat resistance tends to decrease.

상기 화학식 1의 화합물의 대표적인 예는 다음과 같다.
Representative examples of the compound of formula (1) are as follows.

Figure pat00005
(1),
Figure pat00006
(2),
Figure pat00007
(3),
Figure pat00008
(4),
Figure pat00009
(5),
Figure pat00010
(6),
Figure pat00011
(7),
Figure pat00012
(8),
Figure pat00013
(9),
Figure pat00014
(10),
Figure pat00015
(11),
Figure pat00016
(12),
Figure pat00005
(One),
Figure pat00006
(2),
Figure pat00007
(3),
Figure pat00008
(4),
Figure pat00009
(5),
Figure pat00010
(6),
Figure pat00011
(7),
Figure pat00012
(8),
Figure pat00013
(9),
Figure pat00014
(10),
Figure pat00015
(11),
Figure pat00016
(12),

Figure pat00017
(13),
Figure pat00018
(14),
Figure pat00019
(15),
Figure pat00017
(13),
Figure pat00018
(14),
Figure pat00019
(15),

Figure pat00020
(16),
Figure pat00021
(17),
Figure pat00022
(18),
Figure pat00023
(19),
Figure pat00024
(20),
Figure pat00025
(21),
Figure pat00026
(22),
Figure pat00027
(23),
Figure pat00020
(16),
Figure pat00021
(17),
Figure pat00022
(18),
Figure pat00023
(19),
Figure pat00024
(20),
Figure pat00025
(21),
Figure pat00026
(22),
Figure pat00027
(23),

Figure pat00028
(24),
Figure pat00029
(25),
Figure pat00030
(26),
Figure pat00031
(27),
Figure pat00032
(28),
Figure pat00033
(29),
Figure pat00034
(30),
Figure pat00035
(31),
Figure pat00028
(24),
Figure pat00029
(25),
Figure pat00030
(26),
Figure pat00031
(27),
Figure pat00032
(28),
Figure pat00033
(29),
Figure pat00034
(30),
Figure pat00035
(31),

Figure pat00036
(32),
Figure pat00037
(33),
Figure pat00036
(32),
Figure pat00037
(33),

Figure pat00038
(34),
Figure pat00039
(35),
Figure pat00040
(36),
Figure pat00041
(37),
Figure pat00042
(38),
Figure pat00043
(39),
Figure pat00044
(40),
Figure pat00045
(41).
Figure pat00046
(42),
Figure pat00047
(43),
Figure pat00048
(44),
Figure pat00049
(45),
Figure pat00050
(46),
Figure pat00051
(47),
Figure pat00052
(48),
Figure pat00053
(49), 및
Figure pat00054
(50).
Figure pat00038
(34),
Figure pat00039
(35),
Figure pat00040
(36),
Figure pat00041
(37),
Figure pat00042
(38),
Figure pat00043
(39),
Figure pat00044
(40),
Figure pat00045
(41).
Figure pat00046
(42),
Figure pat00047
(43),
Figure pat00048
(44),
Figure pat00049
(45),
Figure pat00050
(46),
Figure pat00051
(47),
Figure pat00052
(48),
Figure pat00053
(49), and
Figure pat00054
(50).

또한, 본 발명의 일례로 하기 반응식 1과 같이 상기 화학식 1로 표시되는 화합물의 제조방법을 제공한다. 하기 반응식 1에서 R1 및 R2의 정의는 상기에서 설명한 바와 같다.Also, as an example of the present invention, there is provided a process for producing a compound represented by the above formula (1) In the following Reaction Scheme 1, the definitions of R 1 and R 2 are as described above.

[반응식 1][Reaction Scheme 1]

Figure pat00055
Figure pat00055

상기 단계 1은, 화학식 1-1로 표시되는 화합물과 카바졸 화합물을 반응시켜 화학식 1-2로 표시되는 화합물을 제조하는 단계이다. 상기 단계에서는 화학식 1-1 화합물, 테트라키스(트리페닐포스핀)팔라듐(0), 3-(9H-카바졸-9-일)페닐보로닉엑시드, 테트라하이드로퓨란을 혼합한 용액에 포타슘 카보네이트 및 물을 첨가하여 반응시키는 것이 바람직하다.
Step 1 is a step of reacting a compound represented by formula (1-1) with a carbazole compound to prepare a compound represented by formula (1-2). In the above step, a solution prepared by mixing a compound of the formula 1-1, tetrakis (triphenylphosphine) palladium (0), 3- (9H-carbazol-9-yl) phenylboronic acid and tetrahydrofuran in a mixture of potassium carbonate And water.

상기 단계 2는, 화학식 1-2로 표시되는 화합물과 화학식 1-6으로 표시되는 화합물을 반응시켜 화학식 1로 표시되는 화합물을 제조하는 단계이다. 상기 단계에서는 화학식 1-2 화합물, 테트라키스(트리페닐포스핀)팔라듐(0), 1-6 화합물, 테트라파이드로퓨란을 혼합한 용액에, 포타슘 카보네이트 및 물을 첨가하여 반응시키는 것이 바람직하다.
Step 2 is a step of reacting a compound represented by formula (1-2) with a compound represented by formula (1-6) to prepare a compound represented by formula (1). In the above step, it is preferable to add potassium carbonate and water to a solution of the compound of the formula 1-2, tetrakis (triphenylphosphine) palladium (0), 1-6 compound and tetrapyridofuran to react.

또한, 본 발명의 일례로 하기 반응식 2와 같이 상기 화학식 1-6으로 표시되는 중간체 화합물의 제조방법을 제공한다. 하기 반응식 2에서 R1 R2의 정의는 상기에서 설명한 바와 같다.Also, as an example of the present invention, there is provided a process for producing an intermediate compound represented by the above Chemical Formula 1-6 as shown in Reaction Scheme 2 below. In the following Reaction Scheme 2, R 1 And The definition of R < 2 > is as described above.

[반응식 2][Reaction Scheme 2]

Figure pat00056
Figure pat00056

상기 단계 1은, 화학식 1-3으로 표시되는 화합물과 카바졸 화합물을 반응시켜 화학식 1-4로 표시되는 화합물을 제조하는 단계이다. 상기 단계에서는 화학식 1-3 화합물, 팔라듐(0)다이아세테이트, 트라이-터트-부틸포스핀, o-자일렌을 혼합한 용액에 포타슘카보네이트 및 카바졸을 첨가하여 반응시키는 것이 바람직하다.
Step 1 is a step of reacting a compound represented by Formula 1-3 with a carbazole compound to prepare a compound represented by Formula 1-4. In the above step, it is preferable to add potassium carbonate and carbazole to the mixed solution of the compound of Formula 1-3, palladium (0) diacetate, tri-tert-butylphosphine and o-xylene to perform the reaction.

상기 단계 2는, 화학식 1-4로 표시되는 화합물을 엔-브로모석신이미드 및 다이메틸포름아마이드와 반응시켜 화학식 1-5로 표시되는 화합물을 제조하는 단계이다.
Step 2 is a step of reacting a compound represented by Formula 1-4 with en-bromosuccinimide and dimethylformamide to prepare a compound represented by Formula 1-5.

상기 단계 3은, 화학식 1-5로 표시되는 화합물을 노르말-부틸리튬 및 트라이에틸보레이트와 반응시켜 화학식 1-6으로 표시되는 화합물을 제조하는 단계이다. 상기 단계에서는 테트라하이드로퓨란을 용매로서 사용하는 것이 바람직하다.
Step 3 is a step of reacting a compound represented by the formula (1-5) with n-butyl lithium and triethyl borate to prepare a compound represented by the formula (1-6). In this step, tetrahydrofuran is preferably used as a solvent.

또한, 본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기발광소자를 제공한다. 이때, 상기 유기층은 발광층을 필수적으로 포함하며, 발광층 외에도 정공주입층, 정공수송층, 전자주입층, 전자수송층 또는 이들의 적층체를 포함할 수 있다.
Also, the present invention provides an organic light emitting device including the compound represented by Formula 1. At this time, the organic layer essentially includes a light emitting layer and may include a hole injecting layer, a hole transporting layer, an electron injecting layer, an electron transporting layer, or a laminate thereof in addition to the light emitting layer.

또한, 본 발명은 음극과 양극 사이에 적어도 하나의 발광층을 포함하는 단층 또는 복수층으로 이루어지는 유기 박막층이 협지되어 있는 유기전기발광소자에 있어서, 상기 유기박막층의 적어도 1층이 상기 화학식 1로 표시되는 화합물을 포함하는 유기발광소자를 함유하는 유기전기발광소자를 제공한다.
The organic electroluminescent device according to the present invention is characterized in that at least one layer of the organic thin film layer is represented by the above formula (1), wherein the organic thin film layer comprises a single layer or a plurality of organic thin film layers sandwiching a cathode and an anode, An organic electroluminescent device comprising an organic electroluminescent device comprising a compound.

본 발명의 유기전기발광소자는 양극, 음극, 및 상기 두 전극 사이에 적어도 하나의 발광층을 함유하는 단층 또는 다층으로 이루어진 유기층을 포함하며, 상기 유기층 중 1층 이상의 층이 상기 화학식 1의 신규 화합물을 함유한다. 예를 들어, 다층형 유기전기발광소자는 아래부터 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극의 다층 구조로 적층된다.
The organic electroluminescent device of the present invention comprises a positive electrode, a negative electrode, and a single layer or multilayer organic layer containing at least one luminescent layer between the two electrodes, wherein at least one layer of the organic layer comprises a novel compound of the formula . For example, a multilayer organic electroluminescent device is laminated from the bottom in a multilayer structure of a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, an electron injecting layer and a cathode.

본 발명에 따른 유기전기발광소자의 기판, 양극 및 음극은 통상적인 유기전기발광소자에 사용되는 물질로 이루어지며, 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 각각은 화학식 1의 화합물, 통상적으로 사용되는 물질 또는 이들의 혼합물로 이루어질 수 있다.
The substrate, the anode, and the cathode of the organic electroluminescent device according to the present invention are made of a material used in a conventional organic electroluminescent device, and each of the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, , Materials conventionally used, or mixtures thereof.

특히, 발광층의 경우, 본 발명의 화학식 1의 화합물을 사용하거나, 발광 호스트(host) 물질 또는 도판트(dopant) 물질로서 사용하여 공지된 다른 발광 도판트 물질 또는 호스트 물질과 함께 사용할 수 있다. 화학식 1의 화합물을 단독 발광물질 또는 호스트 물질로서 사용할 경우에는 발광층 대비 100 내지 80 중량%의 양으로 첨가할 수 있고, 도판트 물질로서 사용할 경우에는 발광층 대비 0.01 내지 20 중량%의 양으로 첨가할 수 있다. 화학식 1의 화합물과 함께 발광층에 사용할 수 있는 발광 물질, 호스트 물질 또는 도판트 물질의 구체적인 예로는 안트라센, 나프탈렌, 페난트렌, 파이렌, 테트라센, 코로넨, 크라이센, 플루오레세인, 페릴렌, 프탈로페릴렌, 페리논, 프탈로페리논, 나프탈로페리논, 다이페닐부타다이엔, 테트라페닐부타다이엔, 쿠마린, 옥사다이아졸, 알다진, 비스벤족사졸린, 비스스타이릴, 피라진, 사이클로펜타다이엔, 퀴놀린 금속 착체, 아미노퀴놀린 금속 착체, 벤조퀴놀린 금속 착체, 이민, 다이페닐에틸렌, 비닐안트라센, 다이아미노카바졸, 피란, 티오피란, 폴리메틴, 멜로사이아닌, 이미다졸 킬레이트화 옥시노이드 화합물, 퀴나크리돈, 루브렌, 형광 색소 및 이들의 혼합물을 들 수 있지만, 이들에 한정되는 것은 아니다. 도판트 물질을 선택할 경우, 고효율의 형광 또는 인광을 가지면서 호스트 물질의 밴드갭(bandgap)보다 같거나 작은 밴드갭을 갖는 것을 선택하는 것이 바람직하다.
In particular, in the case of the light emitting layer, the compound of the formula (1) of the present invention can be used or can be used together with other known light emitting dopant materials or host materials used as a light emitting host material or a dopant material. When the compound of the formula (1) is used as a single luminescent material or a host material, it may be added in an amount of 100 to 80% by weight relative to the light emitting layer, and when it is used as a dopant material, it may be added in an amount of 0.01 to 20% have. Specific examples of the light emitting material, the host material or the dopant material which can be used in the light emitting layer together with the compound of the formula (1) include anthracene, naphthalene, phenanthrene, pyrene, tetracene, coronene, klysene, fluorene, perylene, But are not limited to, phthalocyanine, phthaloyl perylene, phthalo perylene, perinone, phthalo perinone, naphthalo perlinone, diphenylbutadiene, tetraphenylbutadiene, coumarin, oxadiazole, aldazine, bisbenzoxazoline, Anthraquinone metal complexes, cyclopentadiene, quinoline metal complexes, aminoquinoline metal complexes, benzoquinoline metal complexes, imines, diphenylethylene, vinyl anthracene, diaminocarbazole, pyran, thiopyran, polymethine, Quinacridone, rubrene, fluorescent dyes, and mixtures thereof, but are not limited thereto. When a dopant material is selected, it is preferable to select a dopant having a bandgap equal to or less than the bandgap of the host material while having high efficiency of fluorescence or phosphorescence.

유기전기발광소자를 구성하는 각각의 층은 진공 증착, 스퍼터링, 플라즈마, 이온 도금 등의 건식 성막법, 또는 방사 피복, 침지 피복, 유동 피복 등의 습식성막법 중 임의의 통상적인 방법을 적용하여 형성시킬 수 있다. 막 두께는 특별히 한정되지 않으나, 막 두께가 너무 두꺼우면 일정한 광 출력을 얻기 위해 높은 인가전압이 필요하여 효율이 나빠지고, 막 두께가 너무 얇으면 핀홀(pinhole) 등이 발생하여 전기장을 인가하여도 충분한 발광 휘도가 얻어지지 않는다. 통상적인 막 두께는 5 nm 내지 10 ㎛의 범위가 바람직하나, 50 nm 내지 400 nm의 범위가 더욱 바람직하다.
Each of the layers constituting the organic electroluminescent device may be formed by any of a conventional film forming method such as vacuum deposition, sputtering, plasma or ion plating, or a wet film forming method such as spin coating, immersion coating, . The film thickness is not particularly limited, but if the film thickness is too thick, a high applied voltage is required to obtain a constant light output, which leads to poor efficiency. If the film thickness is too thin, pinholes or the like may be generated, Sufficient light emission luminance can not be obtained. A typical film thickness is preferably in the range of 5 nm to 10 mu m, more preferably in the range of 50 nm to 400 nm.

본 발명에 따른 피리딘-피리미딘 유도체 및 이를 포함하는 유기전기발광소자는, 발광 효율 및 열안정성이 우수하면서 적색 및 청색 인광까지의 모든 발광층에 적용할 수 있으므로 벽결이 TV 등의 평판 디스플레이, 조명 또는 디스플레이의 배면광 등의 다양한 유기전기발광소자에 사용될 수 있다.
The pyridine-pyrimidine derivative according to the present invention and the organic electroluminescence device including the same can be applied to all the light emitting layers ranging from red to blue phosphors with excellent luminous efficiency and thermal stability. A backlight of a display, and the like.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for describing the present invention more specifically, and the scope of the present invention is not limited by these examples.

실시예Example 1 One

하기 반응식으로 실시예 1의 화합물을 제조하였다.The compound of Example 1 was prepared by the following reaction scheme.

Figure pat00057

Figure pat00057

1) 중간체 1-2의 합성1) Synthesis of intermediate 1-2

500ml 3구 둥근바닥플라스크에 1-1 화합물(7g), 테트라키스(트리페닐포스핀)팔라듐(0)(1.0g), 3-(9H-카바졸-9-일)페닐보로닉엑시드(10.6g), 테트라하이드로퓨란(140ml)을 넣고 상온의 아르곤 분위기 상에서 1시간 교반하였다. 이 혼합액에 포타슘 카보네이트 (12.8g)와 물(70ml)을 넣고 약 70℃로 가열하면서 12 시간 동안 환류시켰다. 반응종결 후 상온으로 냉각시키고 이 반응액을 층 분리를 통해 유기층을 물로 2회 세척하였다. 얻어진 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 다이클로로메탄과 헥산을 이용한 컬럼 분리를 통해 중간체 1-2를 5.3g 수득하였다.
(7 g), tetrakis (triphenylphosphine) palladium (0) (1.0 g) and 3- (9H-carbazol-9-yl) phenylboronic acid 10.6 g) and tetrahydrofuran (140 ml) were added, and the mixture was stirred in an argon atmosphere at room temperature for 1 hour. Potassium carbonate (12.8 g) and water (70 ml) were added to the mixed solution, and the mixture was refluxed for 12 hours while heating to about 70 캜. After completion of the reaction, the mixture was cooled to room temperature, and the reaction solution was separated by layer separation, and the organic layer was washed twice with water. The obtained organic layer was dried with magnesium sulfate and concentrated under reduced pressure to remove the solvent. The material formed by concentration was subjected to column separation using dichloromethane and hexane to obtain 5.3 g of intermediate 1-2.

2) 2) 실시예Example 1의 화합물의 합성 1 < / RTI >

500ml 3구 둥근바닥플라스크에 1-2 화합물(7g), 테트라키스(트리페닐포스핀)팔라듐(0)(1.0g), (9-페닐-9H-카바졸-3-일)보로닉엑시드(5.6g), 테트라하이드로퓨란(140ml)을 넣고 상온의 아르곤 분위기 상에서 1시간 교반하였다. 이 혼합액에 포타슘 카보네이트(6.7g)와 물(40ml)을 넣고 약 70℃로 가열하면서 12 시간 동안 환류시켰다. 반응종결 후 상온으로 냉각시키고 이 반응액을 층 분리를 통해 유기층을 물로 2회 세척하였다. 얻어진 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 다이클로로메탄과 헥산을 이용한 컬럼 분리를 통해 실시예 2의 화합물을 5.1g 수득하였다.
(7 g), tetrakis (triphenylphosphine) palladium (0) (1.0 g) and (9-phenyl-9H-carbazol-3-yl) boronic acid 5.6 g) and tetrahydrofuran (140 ml) were added, and the mixture was stirred in an argon atmosphere at room temperature for 1 hour. Potassium carbonate (6.7 g) and water (40 ml) were added to the mixture, and the mixture was refluxed for 12 hours while being heated to about 70 캜. After completion of the reaction, the mixture was cooled to room temperature, and the reaction solution was separated by layer separation, and the organic layer was washed twice with water. The obtained organic layer was dried with magnesium sulfate and concentrated under reduced pressure to remove the solvent. 5.1 g of the compound of Example 2 was obtained through column separation using dichloromethane and hexane.

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.94(8H, m), 7.63-7.50(11H, m), 7.33-7.25(4H, m) (200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, m), 7.63-7.50 (11H, m), 7.33-7.25 (4H, m) (8H, m) 200 MHz 1 H-NMR chemical shift (隆), CDCl 3 )

실시예Example 2 2

하기 반응식으로 실시예 2의 화합물을 제조하였다.The compound of Example 2 was prepared by the following reaction scheme.

Figure pat00058
Figure pat00058

1) 중간체 1-2의 합성1) Synthesis of intermediate 1-2

상기에서 기술한 바와 동일한 방법에 의해서 중간체 1-2의 화합물을 합성하였다.The compound of Intermediate 1-2 was synthesized by the same method as described above.

2) 중간체 2-6의 합성2) Synthesis of intermediate 2-6

중간체 2-6은 하기의 합성 방법으로 제조하였다.Intermediate 2-6 was prepared by the following synthesis method.

Figure pat00059
Figure pat00059

2-a) 중간체 1-4의 합성2-a) Synthesis of intermediate 1-4

250ml 3구 둥근바닥플라스크에 1-3 화합물(5g), 팔라듐(0)다이아세테이트(0.04g), 트라이-터트-부틸포스핀(0.23g), o-자일렌(100ml)을 넣고 상온의 아르곤 분위기 상에서 1시간 동안 교반하였다. 이 혼합액에 포타슘카보네이트(7.9g), 카바졸(3.8g)을 첨가한 뒤 120℃에서 8시간 동안 교반하였다. 물을 첨가한 후 에틸아세테이트로 추출하고 수분을 제거한 후 생성된 물질을 다이클로로메탄과 헥산을 이용한 컬럼 분리를 통해 중간체 1-4 화합물 5.6g을 얻었다.
1-3 compound (5 g), palladium (0) diacetate (0.04 g), tri-tert-butylphosphine (0.23 g) and o-xylene (100 ml) were placed in a 250 ml three- And the mixture was stirred for 1 hour in an atmosphere. Potassium carbonate (7.9 g) and carbazole (3.8 g) were added to the mixed solution, followed by stirring at 120 ° C for 8 hours. Water was added, and the mixture was extracted with ethyl acetate, and the water was removed. The resulting material was subjected to column separation using dichloromethane and hexane to obtain 5.6 g of an intermediate 1-4 compound.

2-b) 중간체 1-5의 합성2-b) Synthesis of intermediate 1-5

250ml 3구 둥근바닥플라스크에 1-4 화합물(6g), 엔-브로모석신이미드(3.0g), 다이메틸포름아마이드(60ml)를 넣고 40℃에서 3시간 반응 후 물 20ml를 넣고 메탄올과 헥산을 이용하여 고체상태의 물질을 거름종이로 걸러준 후 다이클로로메탄과 헥산을 이용한 컬럼 분리를 통하여 중간체 1-5 화합물 5.2g을 얻었다.
To a 250 ml three-necked round bottom flask, 1-4 compounds (6 g), enbromosuccinimide (3.0 g) and dimethylformamide (60 ml) were added and reacted at 40 ° C for 3 hours. 20 ml of water was added, , The solid material was filtered off with a filter paper and then subjected to column separation using dichloromethane and hexane to obtain 5.2 g of an intermediate compound 1-5.

2-b) 중간체 2-6의 합성2-b) Synthesis of intermediate 2-6

250ml 3구 둥근바닥플라스크에 1-5 화합물(10g)을 정제한 테트라하이드로퓨란(120ml)에 녹인 뒤 -78℃의 극저온과 아르곤 분위기 상에서 30분 동안 교반하였다. 이 혼합액에 2몰 농도의 노르말-부틸리튬(14ml)을 같은 분위기에서 천천히 적하한 뒤 1시간 동안 교반하였다. 이 반응용액에 트라이아이소프로필보레이트(5.9ml)를 같은 온도에서 천천히 적하시키고 2시간 동안 교반한 다음 상온에서 12시간 동안 교반하였다. 반응종결 후 물을 첨가하여 15분 동안 교반한 용액에 pH 5까지 2노르말 농도의 염산을 첨가한 뒤 4시간 동안 교반하였다. 이를 헥산을 이용하여 거름종이로 고체상의 물질을 걸러 중간체 2-6 화합물 5g을 얻었다.
1-5 compound (10 g) was dissolved in purified tetrahydrofuran (120 ml) into a 250 ml three-neck round bottom flask and stirred for 30 minutes at -78 ° C and argon atmosphere. N-butyl lithium (14 ml) of 2 molar concentration was slowly added dropwise to the mixed solution in the same atmosphere, followed by stirring for 1 hour. To this reaction solution, triisopropyl borate (5.9 ml) was slowly added dropwise at the same temperature, stirred for 2 hours, and then stirred at room temperature for 12 hours. After completion of the reaction, water was added thereto, and the mixture was stirred for 15 minutes. To the solution was added 2N hydrochloric acid to pH 5, followed by stirring for 4 hours. The solid material was filtered off with a filter paper using hexane to obtain 5 g of an intermediate 2-6 compound.

3) 3) 실시예Example 2의 화합물의 합성 2 < / RTI >

250ml 3구 둥근바닥플라스크에 1-2(7g), 테트라키스(트리페닐포스핀)팔라듐(0)(0.56g), 1-6(7.6g), 테트라하이드로퓨란(120ml)을 넣고 상온의 아르곤 분위기 상에서 1시간 교반하였다. 이 혼합액에 포타슘 카보네이트 (6.7g)와 물(25ml)을 넣고 약 70℃로 가열하면서 12 시간 동안 환류시켰다. 반응종결 후 상온으로 냉각시키고 이 반응액을 층 분리를 통해 유기층을 물로 2회 세척하였다. 얻어진 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 다이클로로메탄과 헥산을 이용한 컬럼 분리를 통해 실시예 2의 화합물을 5.1g 수득하였다.
1-2 (7 g), tetrakis (triphenylphosphine) palladium (0) (0.56 g), 1-6 (7.6 g) and tetrahydrofuran (120 ml) were placed in a 250 ml three- And the mixture was stirred for 1 hour in an atmosphere. Potassium carbonate (6.7 g) and water (25 ml) were added to the mixture, and the mixture was refluxed for 12 hours while heating to about 70 캜. After completion of the reaction, the mixture was cooled to room temperature, and the reaction solution was separated by layer separation, and the organic layer was washed twice with water. The obtained organic layer was dried with magnesium sulfate and concentrated under reduced pressure to remove the solvent. 5.1 g of the compound of Example 2 was obtained through column separation using dichloromethane and hexane.

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.89(9H, m), 7.80(1H, s), 7.66-7.50(9H, m), 7.38-7.25(6H, m) (200MHz 1H-NMR chemical shift(δ), CDCl3)
(9H, m), 7.38-7.89 (9H, m), 7.80 (1H, s) 7.25 (6H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 3 내지  3 to 실시예Example 50 50

상기 실시예 1에 기재된 방법과 중간체 1-5의 화합물을 변경한 것을 제외하고, 상기 실시예 1과 동일한 공정을 수행하여 실시예 3 내지 실시예 50의 화합물을 수득하였다. 각각의 실시예의 NMR 데이터는 하기에 나타내었다.
The compounds of Examples 3 to 50 were obtained by carrying out the same processes as in Example 1 except for changing the method described in Example 1 and the compound of Intermediate 1-5. NMR data of each example is shown below.

실시예Example 3 3

Figure pat00060
Figure pat00060

9.22(1H, s), 9.00(2H, s), 8.69(1H, d), 8.60-8.55(2H, m), 8.30-8.28(2H, m), 8.20-8.12(4H, m), 8.03(1H, d), 7.94-7.89(3H, m), 7.73-7.25(15H, m) (200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 8.20-8.12 (4H, m), 8.03 (2H, 1H, d), 7.94-7.89 (3H , m), 7.73-7.25 (15H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 4 4

Figure pat00061
Figure pat00061

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.36-8.28(3H, m), 8.20(2H, s), 8.12-7.94(3H, m), 7.63-7.45(11H, m), 7.33-7.25(3H, m), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(3H, m), 8.36-8.28 (3H, m), 8.20 (2H, s), 8.12-7.94 (3H, m), 7.63 7.45 (11H, m), 7.33-7.25 (3H, m), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 5 5

Figure pat00062
Figure pat00062

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.36-7.89(9H, m), 7.80(1H, s), 7.66-7.50(9H, m), 7.38-7.25(5H, m), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(9H, m), 7.38-7.89 (9H, m), 7.80 (1H, s) 7.25 (5H, m), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 6 6

Figure pat00063
Figure pat00063

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.36-7.89(10H, m), 7.73(1H, s), 7.66-7.25(13H, m), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, s), 7.66-7.25 (1H, m), 1.35 (1H, 9H, s) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 7 7

Figure pat00064
Figure pat00064

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.94(7H, m), 7.77(1H, s), 7.63-7.45(10H, m) 7.33-7.29(4H, m) 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, s), 9.32 (1H, s), 9.00 (2H, s), 8.69-8.55 (3H, m), 8.30-7.94 (4H, m) 0.25 (9H , s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 8 8

Figure pat00065
Figure pat00065

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.77(10H, m), 7.66-7.50(8H, m) 7.38-7.25(6H, m) 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(6H, m) 0.25 (1H, m), 9.22 (1H, s), 9.00 (2H, s), 8.69-8.55 (3H, m), 8.30-7.77 9H, s) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 9 9

Figure pat00066
Figure pat00066

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.89(9H, m), 7.77-7.25(15H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
9.22 (1H, s), 9.00 (2H, s), 8.69-8.55 (3H, m), 8.30-7.89 (9H, m), 7.77-7.25 (15H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ) , CDCl 3)

실시예Example 10 10

Figure pat00067
Figure pat00067

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.87(18H, m), 7.77(1H, s), 7.69-7.25(18H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, s), 7.69-7.25 (18H, m) (200 MHz, 1 H), 9.22 (1H, s), 9.00 (2H, s), 8.69-8.55 (3H, m), 8.30-7.87 H-NMR chemical shift (δ) , CDCl 3)

실시예Example 11 11

Figure pat00068
Figure pat00068

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.63(11H, m), 7.54-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.30-8.28 (2H, m), 8.20 (2H, s), 8.12-7.63 (11H, m), 7.54-8. 7.25 (14H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 12 12

Figure pat00069
Figure pat00069

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.63(15H, m), 7.54-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M) (200 MHz 1 H-NMR chemical shift (隆 (CDCl 3), 隆 (CDCl 3) ), CDCl 3)

실시예Example 13 13

Figure pat00070

Figure pat00070

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-7.87(8H, m), 7.77(1H, s), 7.69-7.45(10H, m), 7.33-7.25(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, s), 7.69-7.45 (10H, m), 7.33-7.87 (1H, 7.25 (3H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 14 14

Figure pat00071
Figure pat00071

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.63(11H, m), 7.54-7.50(4H, m), 7.38-7.25(5H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.30-8.28 (2H, m), 8.20 (2H, s), 8.12-7.63 (11H, m), 7.54-8. 7.50 (4H, m), 7.38-7.25 (5H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3 )

실시예Example 15 15

Figure pat00072
Figure pat00072

9.22(1H, s), 9.00(2H, s), 8.69(1H, d), 8.60-8.55(2H, m), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.63(11H, m), 7.54-7.50(4H, m), 7.38-7.25(5H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.20 (2H, s), 8.12-7.63 (2H, m), 8.30 11H, m), 7.54-7.50 (4H , m), 7.38-7.25 (5H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (隆), CDCl 3 )

실시예Example 16 16

Figure pat00073
Figure pat00073

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12(2H, d), 8.03-7.94(5H, m), 7.63-7.47(9H, m), 7.33-7.25(4H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)M), 8.20 (2H, s), 8.12 (2H, s), 8.69-8.55 (3H, m), 8.45 d), 8.03-7.94 (5H, m ), 7.63-7.47 (9H, m), 7.33-7.25 (4H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 17 17

Figure pat00074
Figure pat00074

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.20(4H, m), 8.12-7.94(7H, m), 7.63-7.49(9H, m), 7.33-7.25(4H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 7.63 (1H, d), 9.22 (1H, s), 9.00 (2H, s), 8.69-8.55 (3H, m), 8.45 7.49 (9H, m), 7.33-7.25 (4H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 18 18

Figure pat00075
Figure pat00075

9.22(1H, s), 9.00(2H, s), 8.60-8.55(3H, m), 8.30-8.12(7H, m), 7.94(2H, d), 7.63-7.45(9H, m), 7.33-7.25(5H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, d), 7.63-7.45 (9H, m), 7.33-7. 9 (2H, s) 7.25 (5H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 19 19

Figure pat00076
Figure pat00076

9.22(1H, s), 9.00(2H, s), 8.69-8.28(7H, m), 8.20 (2H, s), 8.12-7.94(6H, m), 7.62-7.47(9H, m), 7.33-7.25(3H, m), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(9H, m), 7.33 (2H, s), 9.22 (1H, s), 9.00 (2H, s), 8.69-8.28 7.25 (3H, m), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 20 20

Figure pat00077
Figure pat00077

9.22(1H, s), 9.00(2H, s), 8.69-8.28(7H, m), 8.20 (2H, s), 8.12-7.94(6H, m), 7.63-7.49(9H, m), 7.33-7.25(3H, m), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(9H, m), 7.33-7.28 (2H, m), 9.22 (1H, s), 9.00 7.25 (3H, m), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 21 21

Figure pat00078
Figure pat00078

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.35-8.30(3H, m), 8.20-8.12(5H, m), 7.94(1H, d), 7.63-7.45(9H, m), 7.33-7.25(3H, m), 7.03(1H, d), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, d), 7.63 (1H, s), 9.22 (1H, s), 9.00 (2H, s), 8.60-8.49 (3H, m), 8.35-8.30 7.45 (9H, m), 7.33-7.25 (3H, m), 7.03 (1H, d), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 22 22

Figure pat00079
Figure pat00079

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12(1H, d), 8.03-7.94(5H, m), 7.77(1H, s), 7.61-7.47(8H, m), 7.33-7.25(4H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.20 (2H, s), 8.12 (1H, s), 8.30-8.55 (3H, m), 8.45 m), 0.25 (9H, s) (200MHz, 1 H-NMR, CDCl 3) d), 8.03-7.94 (5H, m), 7.77 (1H, s), 7.61-7.47 shift (隆), CDCl 3 )

실시예Example 23 23

Figure pat00080
Figure pat00080

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.05-7.94(6H, m), 7.77(1H, s), 7.61-7.47(8H, m), 7.33-7.25(4H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.30 (2H, s), 8.05-7.94 (2H, s), 9.22 (1H, s), 9.00 6H, m), 7.77 (1H , s), 7.61-7.47 (8H, m), 7.33-7.25 (4H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3 )

실시예Example 24 24

Figure pat00081
Figure pat00081

9.22(1H, s), 9.00(2H, s), 8.61-8.52(4H, m), 8.30(1H, d), 8.20(2H, s), 8.13-8.10(3H, m), 7.94(1H, d), 7.63-7.45(10H,m), 7.33-7.22(4H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 7.94 (1H, s), 9.22 (1H, s), 9.00 (2H, s), 8.61-8.52 (4H, m), 8.30 d), 7.63-7.45 (10H, m ), 7.33-7.22 (4H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 25 25

Figure pat00082
Figure pat00082

9.22(1H, s), 9.00(2H, s), 8.69(1H, d), 8.60-8.55(2H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12(1H, d), 8.03-7.87(6H, m), 7.77(1H, s), 7.69-7.63(2H, m), 7.54-7.25(14H, m) (200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 8.20 (2H, m), 9.22 (1H, s), 9.00 s), 8.12 (1H, d ), 8.03-7.87 (6H, m), 7.77 (1H, s), 7.69-7.63 (2H, m), 7.54-7.25 (14H, m) (200MHz 1 H-NMR chemical shift (隆), CDCl 3 )

실시예Example 26 26

Figure pat00083
Figure pat00083

9.22(1H, s), 9.00(2H, s), 8.69(1H, d), 8.60-8.55(2H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.87(7H, m), 7.77(1H, s), 7.69-7.63(2H, m), 7.54-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 8.20 (2H, m), 9.22 (1H, s), 9.00 s), 8.12-7.87 (7H, m ), 7.77 (1H, s), 7.69-7.63 (2H, m), 7.54-7.25 (14H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3 )

실시예Example 27 27

Figure pat00084
Figure pat00084

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.20(3H, m), 8.13-8.10(3H, m), 7.94(1H, d), 7.63-7.25(18H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 7.94 (2H, d), 8.21-8.20 (3H, m), 8.13-8.10 (3H, 1H, d), 7.63-7.25 (18H , m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 28 28

Figure pat00085
Figure pat00085

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.87(7H, m), 7.77(1H, s), 7.69-7.63(2H, d), 7.54-7.47(6H, m), 7.33-7.29(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 8.20 (2H, s), 8.12-7.87 (2H, (2H, m), 7.77 (1H, s), 7.69-7.63 (2H, d), 7.54-7.47 (6H, m), 7.33-7.29 s), 2.34 (3H, s) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 29 29

Figure pat00086
Figure pat00086

9.22(1H, s), 9.00(2H, s), 8.69-8.55(3H, m), 8.45(1H, d), 8.30-8.28(2H, m), 8.20(2H, s), 8.12-7.87(7H, m), 7.77(1H, s), 7.69-7.63(2H, d), 7.54-7.49(6H, m), 7.33-7.29(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 8.20 (2H, s), 8.12-7.87 (2H, (2H, m), 7.77 (1H, s), 7.69-7.63 (2H, d), 7.54-7.49 (6H, m), 7.33-7.29 s), 2.34 (3H, s) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 30 30

Figure pat00087
Figure pat00087

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.10(6H, m), 7.94(1H, d), 7.63-7.45(10H, m), 7.33-7.29(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s) (200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, d), 7.63-7.45 (2H, s), 9.22 (1H, s), 9.00 3H, s) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 ), 7.33-7.29 (3H, m)

실시예Example 31 31

Figure pat00088
Figure pat00088

9.22(1H, s), 9.00(2H, s), 8.60-8.55(3H, m), 8.30-8.12(7H, m), 7.94-7.89(3H, m), 7.80(1H, s), 7.66-7.50(7H, m), 7.38-7.25(7H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 7.80-7.89 (3H, m), 7.80 (1H, s), 7.66-8.55 (3H, m) 7.50 (7H, m), 7.38-7.25 (7H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 32 32

Figure pat00089
Figure pat00089

9.22(1H, s), 9.00(2H, s), 8.60-8.55(3H, m), 8.30-8.12(7H, m), 7.94-7.89(4H, m), 7.73-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, m), 7.30-7.15 (4H, m), 7.92-7.15 200 MHz 1 H-NMR chemical shift (隆), CDCl 3 )

실시예Example 33 33

Figure pat00090
Figure pat00090

9.22(1H, s), 9.00(2H, s), 8.60-8.55(3H, m), 8.45(1H, d), 8.30-8.12(7H, m), 7.98-7.94(5H, m), 7.63-7.47(7H, m), 7.33-7.25(5H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(1H, m), 7.63-7.94 (5H, m), 7.63-7.30 (2H, m) 7.47 (7H, m), 7.33-7.25 (5H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 34 34

Figure pat00091
Figure pat00091

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.35-8.30(3H, m), 8.21-8.12(5H, m), 7.94-7.80(3H, m), 7.66-7.50(7H, m), 7.38-7.25(5H, m), 7.03(1H, d), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(3H, m), 8.35-8.30 (3H, m), 8.21-8.12 (5H, m), 7.94-7.80 (3H, m) 7.66-7.50 (7H, m), 7.38-7.25 (5H, m), 7.03 (1H, d), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 35 35

Figure pat00092
Figure pat00092

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.35-8.30(3H, m), 8.21-8.12(5H, m), 7.94-7.89(3H, m), 7.73(1H, s), 7.66-7.25(11H, m), 7.03(1H, d), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(3H, m), 8.35-8.30 (3H, m), 8.21-8.12 (5H, m), 7.94-7.89 7.73 (1H, s), 7.66-7.25 (11H, m), 7.03 (1H, d), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 36 36

Figure pat00093
Figure pat00093

9.22(1H, s), 9.00(2H, s), 8.60-8.45(4H, m), 8.35-8.30(3H, m), 8.21-8.12(5H, m), 7.98-7.94(4H, m), 7.63(1H, d), 7.54-7.47(6H, m), 7.33-7.25(3H, m), 7.03(1H, d), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.35-8.30 (3H, m), 8.21-8.12 (5H, m), 7.98-7.94 (4H, m), 9.22 (1H, s), 9.00 7.63 (1H, d), 7.54-7.47 (6H, m), 7.33-7.25 (3H, m), 7.03 (1H, d), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 37 37

Figure pat00094
Figure pat00094

9.22(1H, s), 9.00(2H, s), 8.61-8.52(4H, m), 8.30(1H, d), 8.20(2H, s), 8.13-8.10(3H, m), 7.94-7.89(2H, d), 7.80(1H, s), 7.66-7.62(4H, m), 7.54-7.50(4H, m), 7.38-7.22(6H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, s), 9.22 (1H, s), 9.00 (2H, s), 8.61-8.52 (4H, m), 8.30 2H, d), 7.80 (1H , s), 7.66-7.62 (4H, m), 7.54-7.50 (4H, m), 7.38-7.22 (6H, m), 0.25 (9H, s) (200MHz 1 H- NMR chemical shift (δ), CDCl 3)

실시예Example 38 38

Figure pat00095
Figure pat00095

9.22(1H, s), 9.00(2H, s), 8.61-8.52(4H, m), 8.30(1H, d), 8.20(2H, s), 8.13-8.10(3H, m), 7.94-7.89(3H, d), 7.73(1H, s), 7.66-7.62(3H, m), 7.54-7.22(10H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, s), 9.22 (1H, s), 9.00 (2H, s), 8.61-8.52 (4H, m), 8.30 3H, d), 7.73 (1H , s), 7.66-7.62 (3H, m), 7.54-7.22 (10H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3 )

실시예Example 39 39

Figure pat00096
Figure pat00096

9.22(1H, s), 9.00(2H, s), 8.60-8.45(5H, m), 8.30(1H, d), 8.20(2H, s), 8.13-8.10(3H, m), 7.98-7.94(4H, m), 7.63-7.62(2H, m), 7.54-7.47(6H, m), 7.33-7.22(4H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, s), 9.22 (1H, s), 9.00 (2H, s), 8.60-8.45 (5H, m), 8.30 4H, m), 7.63-7.62 (2H , m), 7.54-7.47 (6H, m), 7.33-7.22 (4H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 40 40

Figure pat00097
Figure pat00097

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.20(3H, m), 8.13-8.10(3H, m), 7.94-7.89(2H, d), 7.80(1H, s), 7.66-7.25(18H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.14-8.10 (3H, m), 8.94 (2H, d) 7.89 (2H, d), 7.80 (1H, s), 7.66-7.25 (18H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 41 41

Figure pat00098
Figure pat00098

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.20(3H, m), 8.13-8.10(3H, m), 7.94-7.89(3H, m), 7.73(1H, s), 7.66-7.25(17H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.14-8.10 (3H, m), 8.94 (2H, d) 7.89 (3H, m), 7.73 (1H, s), 7.66-7.25 (17H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 42 42

Figure pat00099
Figure pat00099

9.22(1H, s), 9.00(2H, s), 8.60-8.45(4H, m), 8.30(2H, d), 8.21-8.20(3H, m), 8.13-8.10(3H, m), 7.94-7.89(4H, m), 7.63-7.62(2H, m), 7.66-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(3H, m), 7.94 (1H, m), 9.22 (1H, s), 9.00 (2H, s), 8.60-8.45 7.89 (4H, m), 7.63-7.62 (2H, m), 7.66-7.25 (14H, m) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 43 43

Figure pat00100
Figure pat00100

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.10(6H, m), 7.94-7.89(2H, d), 7.80(1H, s), 7.66-7.50(8H, m), 7.38-7.25(5H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, d), 8.80 (2H, d), 8.21-8.10 (6H, m), 7.94-7.89 1H, s), 7.66-7.50 (8H , m), 7.38-7.25 (5H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (隆), CDCl 3 )

실시예Example 44 44

Figure pat00101
Figure pat00101

9.22(1H, s), 9.00(2H, s), 8.60-8.49(3H, m), 8.30(2H, d), 8.21-8.10(6H, m), 7.94-7.89(3H, m), 7.73(1H, s), 7.63-7.25(12H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 7.73 (2H, d), 8.21-8.10 (6H, m), 7.94-7.89 (3H, 1H, s), 7.63-7.25 (12H , m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 45 45

Figure pat00102
Figure pat00102

9.22(1H, s), 9.00(2H, s), 8.60-8.45(4H, m), 8.30(2H, d), 8.21-8.10(6H, m), 7.98-7.94(4H, m), 7.62-7.47(8H, m), 7.33-7.25(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, s), 8.60-8.45 (4H, m), 8.30 (2H, d), 8.21-8.10 (6H, m), 7.98-7.94 7.47 (8H, m), 7.33-7.25 (3H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3 )

실시예Example 46 46

Figure pat00103
Figure pat00103

9.22(1H, s), 9.00(2H, s), 8.60-8.55(3H, m), 8.45(1H, d), 8.30(2H, d), 8.20-7.94(10H, m), 7.63(1H, d), 7.54-7.49(6H, m), 7.33-7.25(5H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, d), 8.20-7.94 (10H, m), 7.63 (1H, s), 9.60 d), 7.54-7.49 (6H, m), 7.33-7.25 (5H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 47 47

Figure pat00104
Figure pat00104

9.22(1H, s), 9.00(2H, s), 8.60-8.49(4H, m), 8.35-8.30(3H, m), 8.21-8.20(3H, m), 8.12-7.94(6H, m), 7.63(1H, d), 7.54-7.49(6H, m), 7.33-7.25(3H, m), 7.03(1H, d), 1.35(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.21-8.20 (3H, m), 8.12-7.94 (6H, m), 8.35-8.30 (3H, m) 7.63 (1H, d), 7.54-7.49 (6H, m), 7.33-7.25 (3H, m), 7.03 (1H, d), 1.35 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 48 48

Figure pat00105
Figure pat00105

9.22(1H, s), 9.00(2H, s), 8.61-8.45(5H, m), 8.30(1H, d), 8.20(2H, s), 8.13-7.94(7H, m), 7.63-7.62(2H, m), 7.54-7.49(6H, m), 7.33-7.22(4H, m), 0.25(9H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(2H, s), 8.13-7.94 (7H, m), 7.63-7.62 (2H, 2H, m), 7.54-7.49 (6H , m), 7.33-7.22 (4H, m), 0.25 (9H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실시예Example 49 49

Figure pat00106
Figure pat00106

9.22(1H, s), 9.00(2H, s), 8.60-8.45(4H, m), 8.30(2H, d), 8.21-8.20(3H, m), 8.13-7.94(7H, m), 7.63-7.62(2H, m), 7.54-7.25(14H, m)(200MHz 1H-NMR chemical shift(δ), CDCl3)
M), 8.16-7.94 (7H, m), 7.63-8.45 (2H, m), 9.22 (1H, s), 9.00 7.62 (2H, m), 7.54-7.25 (14H, m) (200 MHz 1 H-NMR chemical shift (?), CDCl 3 )

실시예Example 50 50

Figure pat00107
Figure pat00107

9.22(1H, s), 9.00(2H, s), 8.60-8.45(4H, m), 8.30(2H, d), 8.21-7.94(10H, m), 7.63-7.49(8H, m), 7.33-7.25(3H, m), 6.97(2H, s), 3.01(6H, s), 2.34(3H, s)(200MHz 1H-NMR chemical shift(δ), CDCl3)
(8H, m), 7.33-7.94 (8H, m), 9.22 (1H, s), 9.00 7.25 (3H, m), 6.97 (2H, s), 3.01 (6H, s), 2.34 (3H, s) (200MHz 1 H-NMR chemical shift (δ), CDCl 3)

실험예Experimental Example

실험예Experimental Example 1:  One: 실시예Example 1을 사용한 유기 전기발광 소자 제조 Preparation of organic electroluminescent device using

박막 두께가 100 nm 인 ITO 투명 전극을 40 mm X 40 mm X 0.7 m 크기로 재단한 기판을 세제가 용해된 증류수 속에서 10 분 동안 초음파로 세정하고, 증류수에서 10 분 동안 2 회 반복 세정하였다.
An ITO transparent electrode with a thickness of 100 nm was cut to a size of 40 mm × 40 mm × 0.7 m. The substrate was ultrasonically cleaned in distilled water for 10 minutes and washed twice in distilled water for 10 minutes.

증류수 세정이 끝나면 아이소프로필알코올, 아세톤, 메탄올 등의 용제를 순차적으로 초음파 세척하고 건조시켰다. 습식정제 후 산소/아르곤 플라즈마를 이용하여 건식세정을 거친 다음 투명 전극 라인을 갖는 유리 기판을 진공 증착 장치의 기판 홀더에 장착하여, 우선 투명 전극 라인이 형성되어 있는 ITO 측의 면상에, 하기 화학식 A를 가지는 화합물(N1,N1'-(biphenyl-4,4'-diyl)bis(N1-phenyl-N4,N4-dim-tolylbenzene-1,4-diamine)의 DNTPD를 30 nm의 두께로 열 진공 증착하여 정공 주입층을 형성하였다.After the distilled water was washed, solvents such as isopropyl alcohol, acetone and methanol were sequentially ultrasonically washed and dried. After the wet refining, the substrate was dry-cleaned using oxygen / argon plasma, and then a glass substrate having a transparent electrode line was mounted on a substrate holder of a vacuum evaporation apparatus. On the surface of the ITO side on which the transparent electrode line was formed, DNTPD of a compound (N 1 , N 1 ' - (biphenyl-4,4'-diyl) bis (N 1 -phenyl-N 4 , N 4 -dim-tolylbenzene- Lt; RTI ID = 0.0 > vacuum / vacuum < / RTI >

[화학식 A](A)

Figure pat00108

Figure pat00108

상기 화학식 A의 화합물로 된 층 위에 정공 수송을 할 수 있는 하기 화학식 B를 가지는 화합물(N4,N4'-di(naphthalen-1-yl)-N4,N4'-diphenylbiphenyl-4,4'-diamine)의 NPB로 된 층을 20 nm로 진공증착하여 형성하였다.(N 4 , N 4 ' -di (naphthalen-1-yl) -N 4 , N 4' -diphenylbiphenyl-4,4 '-diamine was formed by vacuum deposition at 20 nm.

[화학식 B][Chemical Formula B]

Figure pat00109

Figure pat00109

상기 화학식 B의 화합물로 된 층 위에 전자가 정공 수송층으로 쉽게 흐르는 것을 방지할 수 있는 하기 화학식 C를 가지는 화합물(N-(4-(4aH-carbazol-9(4bH,8aH,9aH)-yl)phenyl)-N-(4-(9H-carbazol-9-yl)phenyl)-4-(9H-carbazol-9-yl)benzenamine)의 TCTA로 된 층을 10 nm로 진공증착하여 형성하였다.(4- (4aH-carbazol-9 (4bH, 8aH, 9aH) -yl) phenyl, which is capable of preventing electrons from easily flowing into the hole transport layer on the layer of the compound of Formula (B) (9H-carbazol-9-yl) benzenamine) was vacuum-deposited to a thickness of 10 nm.

[화학식 C]≪ RTI ID = 0.0 &

Figure pat00110

Figure pat00110

상기 화학식 C의 화합물로 된 층 위에 발광 호스트로서 실시예 1의 화합물과 함께, 청색 도펀트로서 하기 화학식 D로 표시되는 화합물을 5% 농도로 혼합 증착하여 30 nm 두께의 발광층을 형성하였다. A compound represented by the following formula (D) as a blue dopant was mixed and vapor-deposited at a concentration of 5% together with the compound of Example 1 as a light emitting host on the layer of the compound of the formula (C) to form a light emitting layer of 30 nm in thickness.

[화학식 D][Chemical Formula D]

Figure pat00111

Figure pat00111

상기 발광층 위에 전자의 주입 및 수송 역할을 하는 하기 화학식 E의 화합물을 30 nm의 두께로 진공 증착하여 형성하였다.A compound of the following formula (E) serving as an electron injecting and transporting layer was vacuum deposited on the light emitting layer to a thickness of 30 nm.

[화학식 E](E)

Figure pat00112

Figure pat00112

상기 전자주입 및 수송층 위에 순차적으로 0.7 nm 두께의 리튬플로라이드(LiF)와 120 nm 두께의 알루미늄을 증착하여 음극을 형성하였다. 상기와 같이 제작된 유기 전기발광 소자에 6V의 전압으로 측성한 결과 전류밀도가 0.62 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.145, y=0.340에 해당하는 164 cd/㎡ 밝기의 순청색에 가까운 스펙트럼이 관찰되었으며 효율은 26.4 cd/A 이었다.
Lithium fluoride (LiF) with a thickness of 0.7 nm and aluminum with a thickness of 120 nm were sequentially deposited on the electron injection and transport layer to form a cathode. The resulting organic light emitting device was measured at a voltage of 6 V to form a current density of 0.62 mA / cm 2. At this time, a luminance of 164 cd / m 2 corresponding to x = 0.145 and y = 0.340 on the basis of 1931 CIE color coordinates A spectrum close to pure blue was observed and the efficiency was 26.4 cd / A.

실험예Experimental Example 2 2

발광 호스트 재료인 본 발명의 실시예 1의 화합물을 대신하여 본 발명의 실시예 2의 화합물을 발광 호스트 물질로서 사용하는 것을 제외하고, 실험예 1과 동일한 방법으로 유기전기발광소자를 제작하였다. An organic electroluminescent device was fabricated in the same manner as in Experimental Example 1, except that the compound of Example 1 of the present invention, which is a luminescent host material, was used as a luminescent host material.

상기와 같이 제조된 유기 전기발광 소자에 6V의 전압으로 측정한 결과 전류밀도가 0.03 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.151, y=0.327에 해당하는 10.77 cd/㎡ 밝기의 순청색에 가까운 스펙트럼이 관찰되었으며 효율은 30.9cd/A 이었다.
The organic electroluminescent device manufactured as described above was measured at a voltage of 6 V and a current density of 0.03 mA / cm 2 was formed. At this time, x = 0.151 and y = 0.327 on the basis of the CIE color coordinates of 1931, A spectrum close to pure blue was observed and the efficiency was 30.9 cd / A.

실험예Experimental Example 3:  3: 비교예Comparative Example

호스트 재료인 본 발명의 실시예 1을 대신하여 하기 화학식 E로 표시되는 화합물을 발광 호스트 물질로서 사용하는 것을 제외하고, 실험예 1과 동일한 방법으로 유기전기발광소자를 제조하였다.An organic electroluminescence device was prepared in the same manner as in Experimental Example 1, except that the compound represented by the following formula (E) was used as a luminescent host material instead of the host material of Example 1 of the present invention.

[화학식 F][Chemical Formula F]

Figure pat00113

Figure pat00113

상기와 같이 제조된 유기 전기발광 소자에 6V의 전압으로 측정한 결과 전류밀도가 0.13 mA/㎠로 형성되었으며, 이때 1931 CIE 색좌표 기준으로 x=0.147, y=0.332에 해당하는 23 cd/㎡ 밝기의 순청색에 가까운 스펙트럼이 관찰되었으며 효율은 18.1cd/A 이었다.
The organic electroluminescent device manufactured as described above was measured at a voltage of 6 V and a current density of 0.13 mA / cm 2 was formed. The current density was 23 cd / m 2 corresponding to x = 0.147 and y = 0.332 on the basis of 1931 CIE color coordinates. A spectrum close to pure blue was observed and the efficiency was 18.1 cd / A.

Claims (6)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure pat00114

상기 식에서, R1은 페닐, 다이벤조[b,d]퓨라닐 및 다이벤조[b,d]싸이에닐로 구성된 군으로부터 선택되는 어느 하나이고,
R2는 터트-뷰틸, 트리메틸실라닐, 페닐, 및 메시틸로 구성된 군으로부터 선택되는 어느 하나이다.
A compound represented by the following formula (1):
[Chemical Formula 1]
Figure pat00114

Wherein R 1 is any one selected from the group consisting of phenyl, dibenzo [b, d] furanyl and dibenzo [b, d] thienyl,
R 2 is any one selected from the group consisting of tert-butyl, trimethylsilanyl, phenyl, and mesityl.
제1항에 있어서,
상기 화합물이 하기 화학식 1a 또는 하기 화학식 1b로 표시되는 화합물 중 어느 하나인 것을 특징으로 하는 화합물:
[화학식 1a]
Figure pat00115

[화학식 1b]
Figure pat00116
.
The method according to claim 1,
Wherein the compound is any one of compounds represented by the following general formula (1a) or (1b):
[Formula 1a]
Figure pat00115

[Chemical Formula 1b]
Figure pat00116
.
제1항에 있어서, 상기 R2가 카바졸의 6번 또는 7번 위치에 치환된 것을 특징으로 하는 화합물.
The compound of claim 1, wherein R 2 is substituted at position 6 or 7 of the carbazole.
제1항에 있어서, 상기 화합물은

Figure pat00117
(1),
Figure pat00118
(2),
Figure pat00119
(3),
Figure pat00120
(4),
Figure pat00121
(5),
Figure pat00122
(6),
Figure pat00123
(7),
Figure pat00124
(8),
Figure pat00125
(9),
Figure pat00126
(10),
Figure pat00127
(11),
Figure pat00128
(12),

Figure pat00129
(13),
Figure pat00130
(14),
Figure pat00131
(15),
Figure pat00132
(16),
Figure pat00133
(17),
Figure pat00134
(18),
Figure pat00135
(19),
Figure pat00136
(20),
Figure pat00137
(21),
Figure pat00138
(22),
Figure pat00139
(23),
Figure pat00140
(24),
Figure pat00141
(25),
Figure pat00142
(26),
Figure pat00143
(27),
Figure pat00144
(28),
Figure pat00145
(29),
Figure pat00146
(30),
Figure pat00147
(31),
Figure pat00148
(32),
Figure pat00149
(33),
Figure pat00150
(34),
Figure pat00151
(35),
Figure pat00152
(36),
Figure pat00153
(37),
Figure pat00154
(38),
Figure pat00155
(39),
Figure pat00156
(40),
Figure pat00157
(41).
Figure pat00158
(42),
Figure pat00159
(43),
Figure pat00160
(44),
Figure pat00161
(45),
Figure pat00162
(46),
Figure pat00163
(47),
Figure pat00164
(48),
Figure pat00165
(49), 및
Figure pat00166
(50)으로 구성되는 군으로부터 선택되는 화합물.
The compound according to claim 1, wherein the compound is

Figure pat00117
(One),
Figure pat00118
(2),
Figure pat00119
(3),
Figure pat00120
(4),
Figure pat00121
(5),
Figure pat00122
(6),
Figure pat00123
(7),
Figure pat00124
(8),
Figure pat00125
(9),
Figure pat00126
(10),
Figure pat00127
(11),
Figure pat00128
(12),

Figure pat00129
(13),
Figure pat00130
(14),
Figure pat00131
(15),
Figure pat00132
(16),
Figure pat00133
(17),
Figure pat00134
(18),
Figure pat00135
(19),
Figure pat00136
(20),
Figure pat00137
(21),
Figure pat00138
(22),
Figure pat00139
(23),
Figure pat00140
(24),
Figure pat00141
(25),
Figure pat00142
(26),
Figure pat00143
(27),
Figure pat00144
(28),
Figure pat00145
(29),
Figure pat00146
(30),
Figure pat00147
(31),
Figure pat00148
(32),
Figure pat00149
(33),
Figure pat00150
(34),
Figure pat00151
(35),
Figure pat00152
(36),
Figure pat00153
(37),
Figure pat00154
(38),
Figure pat00155
(39),
Figure pat00156
(40),
Figure pat00157
(41).
Figure pat00158
(42),
Figure pat00159
(43),
Figure pat00160
(44),
Figure pat00161
(45),
Figure pat00162
(46),
Figure pat00163
(47),
Figure pat00164
(48),
Figure pat00165
(49), and
Figure pat00166
(50). ≪ / RTI >
제1항 내지 제4항 중 어느 한 항의 화합물을 포함하는 유기발광소자.
An organic electroluminescent device comprising a compound according to any one of claims 1 to 4.
음극과 양극 사이에 적어도 하나의 발광층을 포함하는 단층 또는 복수층으로 이루어지는 유기 박막층이 협지되어 있는 유기전기발광소자에 있어서, 상기 유기박막층의 적어도 1층이 제5항의 유기발광소자를 함유하는 유기전기발광소자.Wherein at least one layer of the organic thin film layer is an organic electroluminescent element containing the organic electroluminescent element of claim 5, wherein the organic electroluminescent element comprises a single layer or a plurality of organic thin film layers sandwiched between a cathode and an anode, Light emitting element.
KR20130046401A 2013-04-25 2013-04-25 Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same KR20140127705A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR20130046401A KR20140127705A (en) 2013-04-25 2013-04-25 Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20130046401A KR20140127705A (en) 2013-04-25 2013-04-25 Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same

Publications (1)

Publication Number Publication Date
KR20140127705A true KR20140127705A (en) 2014-11-04

Family

ID=52451881

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20130046401A KR20140127705A (en) 2013-04-25 2013-04-25 Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same

Country Status (1)

Country Link
KR (1) KR20140127705A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10593890B2 (en) 2015-04-06 2020-03-17 Universal Display Corporation Organic electroluminescent materials and devices
KR20210042038A (en) * 2019-10-08 2021-04-16 주식회사 엘지화학 Compound and organic light emitting device comprising same
US11495749B2 (en) 2015-04-06 2022-11-08 Universal Display Corporation Organic electroluminescent materials and devices
US11818949B2 (en) 2015-04-06 2023-11-14 Universal Display Corporation Organic electroluminescent materials and devices
US11834459B2 (en) 2018-12-12 2023-12-05 Universal Display Corporation Host materials for electroluminescent devices

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10593890B2 (en) 2015-04-06 2020-03-17 Universal Display Corporation Organic electroluminescent materials and devices
US10693082B2 (en) 2015-04-06 2020-06-23 Universal Display Corporation Organic electroluminescent materials and devices
US11245080B2 (en) 2015-04-06 2022-02-08 Universal Display Corporation Organic electroluminescent materials and devices
US11495749B2 (en) 2015-04-06 2022-11-08 Universal Display Corporation Organic electroluminescent materials and devices
US11672175B2 (en) 2015-04-06 2023-06-06 Universal Display Corporation Organic electroluminescent materials and devices
US11818949B2 (en) 2015-04-06 2023-11-14 Universal Display Corporation Organic electroluminescent materials and devices
US11834459B2 (en) 2018-12-12 2023-12-05 Universal Display Corporation Host materials for electroluminescent devices
KR20210042038A (en) * 2019-10-08 2021-04-16 주식회사 엘지화학 Compound and organic light emitting device comprising same

Similar Documents

Publication Publication Date Title
KR101142056B1 (en) Novel aromatic derivatives and organic electroluminescent device comprising same
TWI570984B (en) Organic electronic materials
JP2015216382A (en) New organic electroluminescent compound and organic electroluminescent element using the same
KR20100106014A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20050107620A (en) Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
TW201114880A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20160073914A (en) Novel organic semiconductor compound and organic light emitting device using the same
JP2013530513A (en) Novel organic electroluminescent compound and organic electroluminescent device using the same
KR20120044523A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR101415734B1 (en) Hole transporting material using new arylamine and organic electroluminescent device comprising the same
KR20140127705A (en) Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same
KR101321988B1 (en) Aromatic derivatives and organic electroluminescent device comprising same
KR101375542B1 (en) Hole transporting material comprising thiophen derivative and organic electroluminescent device using the same
KR20130051321A (en) Novel tetiary aryl amine and organic electroluminescent device using the same
KR101327301B1 (en) Amine derivative as hole transporting material and organic electroluminescent device using the same
KR20140127702A (en) 2-(phenylsulfonyl)pyridine derivatives and Organic electroluminescent device comprising same
KR101822987B1 (en) Spyro-typed organic material and organic electroluminescent device utilizing the same
KR20150114658A (en) An organoelectro luminescent compounds and organoelectro luminescent device using the same
KR100754474B1 (en) Anthracene based organic luminescent compound and organic light-emitting diode including the same
TW201404863A (en) Novel organic compound and electroluminescent device comprising same
KR102098920B1 (en) Organic compound comprising boron and organic electroluminescent device comprising the same
KR101883772B1 (en) Benzimidazole derivatives and organic electroluminescent device comprising same
KR101977352B1 (en) Organic compound comprising pyrimidine and organic electroluminescent device comprising the same
JP2008308449A (en) Condensed-ring aromatic compound and organic electroluminescent element
KR20140127701A (en) Diphenyl sulfone derivatives and Organic electroluminescent device comprising same

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid